The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin–angiotensin system
出版年份 2020 全文链接
标题
The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin–angiotensin system
作者
关键词
-
出版物
European Heart Journal-Cardiovascular Pharmacotherapy
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2020-05-08
DOI
10.1093/ehjcvp/pvaa053
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
- (2020) Jin-jin Zhang et al. ALLERGY
- Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics
- (2020) David Gurwitz DRUG DEVELOPMENT RESEARCH
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
- (2020) Matt Arentz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19
- (2020) James H Diaz JOURNAL OF TRAVEL MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drugs and the renin-angiotensin system in covid-19
- (2020) Jeffrey K Aronson et al. BMJ-British Medical Journal
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Renin-Angiotensin System Blockers and the COVID-19 Pandemic
- (2020) A.H. Jan Danser et al. HYPERTENSION
- Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent
- (2019) Peter Serfozo et al. HYPERTENSION
- Fusion of Enveloped Viruses in Endosomes
- (2016) Judith M. White et al. TRAFFIC
- Engineering a nanolab for the determination of lysosomal nitric oxide by the rational design of a pH-activatable fluorescent probe
- (2016) Yinhui Li et al. Chemical Science
- Angiotensin II Mediates Angiotensin Converting Enzyme Type 2 Internalization and Degradation Through an Angiotensin II Type I Receptor–Dependent Mechanism
- (2014) Matthew R. Deshotels et al. HYPERTENSION
- T cell-mediated immune response to respiratory coronaviruses
- (2014) Rudragouda Channappanavar et al. IMMUNOLOGIC RESEARCH
- Multiple Functions of Angiotensin-Converting Enzyme 2 and Its Relevance in Cardiovascular Diseases
- (2013) Keiji Kuba et al. CIRCULATION JOURNAL
- Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
- (2013) Manuel Haschke et al. CLINICAL PHARMACOKINETICS
- Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats
- (2013) Quaisar Ali et al. KIDNEY INTERNATIONAL
- Nitric oxide inhibits the expression of AT1 receptors in neurons
- (2012) Neeru M. Sharma et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- AT1 receptor-mediated angiotensin II activation and chemotaxis of T lymphocytes
- (2011) João Luiz Silva-Filho et al. MOLECULAR IMMUNOLOGY
- Angiotensin II revisited: new roles in inflammation, immunology and aging
- (2010) Ariela Benigni et al. EMBO Molecular Medicine
- Angiotensin II type-1 receptor antagonist attenuates LPS-induced acute lung injury
- (2009) Fei Wang et al. CYTOKINE
- Structural and Energetic Analysis on the Complexes of Clinically Isolated Subtype C HIV-1 Proteases and Approved Inhibitors by Molecular Dynamics Simulation
- (2009) Shou Matsuyama et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Dual effect of nitric oxide on SARS-CoV replication: Viral RNA production and palmitoylation of the S protein are affected
- (2009) Sara Åkerström et al. VIROLOGY
- SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway
- (2008) Hongliang Wang et al. CELL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started